CANNABIS USE, A SELF-MANAGMENT STRATEGY AMOUNT AUSTRALIAN WOMEN WITH ENDOMETRIOSIS: RESULTS FROM A NATIONAL ONLINE SURVEY.
Justin Sinclair, Caroline A. Smith, Jason Abbott, K. Jane Chalmers, David W. Pate, Mike Armour
Journal of Obstretrics and Gynaecology Canada, Volume 42, Issue 3, March 2020, Pages 256-261
The results from an Australian national online survey was released last month into the use of cannabis as a self-management strategy for endometriosis. The survey aimed to determine the occurrence, tolerance and effectiveness of cannabis use for Australian women with endometriosis.
Based on the responses of 484 women, the survey concluded 76% of the participants used general self-management strategies to alleviate endometriosis-associated symptoms within the last 6 months.
13% of those using self-management strategies reported using cannabis. Within this sub-group, self-reported effectiveness in the reduction of pain was high at 7.6 out of 10 and 56% of this group were able to reduce pharmaceutical medications by at least half. The survey participants also reported improvements in sleep, nausea and vomiting.
The survey supports the need for further investigations and clinical research into the effectiveness of cannabis in managing endometriosis.
Pre-clinical studies documenting the anti-cancer effects of THC and its success in inhibiting cancer growth and spread have been on the rise. Clinical studies however are scarce as the psychoactive effects of THC can limit its medicinal and clinical use. Could non-psychoactive cannabinoids found in cannabis and hemp be the answer to treating cancer instead?
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.